Autobio Diagnostics Co Ltd
SSE:603658

Watchlist Manager
Autobio Diagnostics Co Ltd Logo
Autobio Diagnostics Co Ltd
SSE:603658
Watchlist
Price: 41.25 CNY -1.08% Market Closed
Market Cap: 24B CNY
Have any thoughts about
Autobio Diagnostics Co Ltd?
Write Note
Autobio Diagnostics Co Ltd
/
Income Statement
/
Net Income (Common)

Autobio Diagnostics Co Ltd
Net Income (Common)

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Autobio Diagnostics Co Ltd
Net Income (Common) Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Net Income (Common) CAGR 3Y CAGR 5Y CAGR 10Y
Autobio Diagnostics Co Ltd
SSE:603658
Net Income (Common)
¥1.3B
CAGR 3-Years
10%
CAGR 5-Years
13%
CAGR 10-Years
N/A
Shandong Weigao Group Medical Polymer Co Ltd
HKEX:1066
Net Income (Common)
¥1.9B
CAGR 3-Years
-6%
CAGR 5-Years
2%
CAGR 10-Years
N/A
Eyebright Medical Technology Beijing Co Ltd
SSE:688050
Net Income (Common)
¥304m
CAGR 3-Years
47%
CAGR 5-Years
72%
CAGR 10-Years
N/A
S
Shandong Pharmaceutical Glass Co Ltd
SSE:600529
Net Income (Common)
¥882m
CAGR 3-Years
12%
CAGR 5-Years
15%
CAGR 10-Years
22%
Winner Medical Co Ltd
SZSE:300888
Net Income (Common)
¥580.4m
CAGR 3-Years
-47%
CAGR 5-Years
6%
CAGR 10-Years
N/A
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
Net Income (Common)
¥1.7B
CAGR 3-Years
21%
CAGR 5-Years
19%
CAGR 10-Years
N/A
No Stocks Found

Autobio Diagnostics Co Ltd
Glance View

Market Cap
24B CNY
Industry
Health Care

Autobio Diagnostics Co., Ltd. is a company that has carved a distinctive niche in the biotechnology landscape, particularly within the realm of in-vitro diagnostics (IVD). The company's journey began with a mission to enhance healthcare by providing advanced diagnostic tools that offer precise and timely results. Specializing in the development, production, and distribution of diagnostic reagents and instruments, Autobio has dedicated itself to innovation and quality in medical diagnostics. Its expansive product portfolio covers areas such as immunoassay detection, microbiology, clinical chemistry, and molecular diagnostics, catering to both hospital laboratories and independent labs. The firm prides itself on adopting cutting-edge technology to create solutions that are not only efficient and cost-effective but also align with global health standards. The financial heartbeat of Autobio lies in its strategic approach to generating revenue through diverse streams. With a keen focus on research and development, the company continually innovates its product lines, thereby sustaining a competitive edge in the fast-evolving diagnostics market. Additionally, its revenue model capitalizes heavily on the consumables-market; reagents and test kits are used in routine diagnostics, creating a recurring income source as these products need constant replenishment. By expanding its geographic footprint through partnerships and direct sales channels, Autobio enhances its market reach, strengthening its ability to leverage scale economies. Moreover, the company’s commitment to maintaining strong customer relationships through robust after-sales service and technical support has built a loyal base, further fueling its revenue engine.

Intrinsic Value
75.56 CNY
Undervaluation 45%
Intrinsic Value
Price
What is Intrinsic Value?

See Also

What is Autobio Diagnostics Co Ltd's Net Income (Common)?
Net Income (Common)
1.3B CNY

Based on the financial report for Sep 30, 2024, Autobio Diagnostics Co Ltd's Net Income (Common) amounts to 1.3B CNY.

What is Autobio Diagnostics Co Ltd's Net Income (Common) growth rate?
Net Income (Common) CAGR 5Y
13%

Over the last year, the Net Income (Common) growth was 9%. The average annual Net Income (Common) growth rates for Autobio Diagnostics Co Ltd have been 10% over the past three years , 13% over the past five years .

Back to Top
ALPHA SPREAD
Follow us
Join more than 215,500+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.